Small cell lung cancer, or SCLC, is fraught with challenges. Patients are often diagnosed late so outcomes are poor; therapeutic advances have stalled due to lackluster funding and the disease, ...

Key opportunities include biomarker-guided targeted therapies, immunotherapy combinations, liquid biopsies, next-generation resistance treatments, biologics, specialty cold-chain distribution, and ...

Anxiety is common in people living with metastatic non–small-cell lung cancer, and it can interfere with treatment. Get tips ...

A diagnosis of non-small cell lung cancer (NSCLC) can significantly affect emotional health, leading to mental health challenges such as depression, anxiety, and distress. Comprehensive mental health ...

Bayer AG (BAYN.DE,BYR.L) on Thursday announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval for HYRNUO (sevabertinib) as the first-line treatment for adult ...

Ateganosine combined with Libtayo shows improved progression-free survival in advanced non-small cell lung cancer, suggesting potential long-term use. Spevatamig, a bispecific antibody, is being ...

The tumour immune microenvironment in non-small cell lung cancer (NSCLC) comprises a complex network of malignant cells, stromal elements and a diverse array of immune infiltrates whose composition ...

It's natural to feel afraid after a lung cancer diagnosis. But there's also real reason for hope, as treatment for lung cancer has improved dramatically in the last decade. (DigitalVision/Getty Images ...

HER2-mutated non-small-cell lung cancer (NSCLC) is a rare form of lung cancer where the cancer cells have a mutation that makes them grow and divide in an uncontrolled way. You can best understand ...

Ahead of World Cancer Research Day, an oncologist explained why cancers that look alike can respond differently to the same ...